- Home
- WYY vs KALA Comparison
WYY vs KALA Comparison
Compare WYY & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WYY
- KALA
- Stock Information
- Founded
- WYY 1991
- KALA 2009
- Country
- WYY United States
- KALA United States
- Employees
- WYY N/A
- KALA N/A
- Industry
- WYY EDP Services
- KALA Biotechnology: Pharmaceutical Preparations
- Sector
- WYY Technology
- KALA Health Care
- Exchange
- WYY Nasdaq
- KALA Nasdaq
- Market Cap
- WYY 33.6M
- KALA 26.2M
- IPO Year
- WYY 1998
- KALA 2017
- Fundamental
- Price
- WYY $2.96
- KALA $7.14
- Analyst Decision
- WYY Strong Buy
- KALA Strong Buy
- Analyst Count
- WYY 1
- KALA 3
- Target Price
- WYY $7.00
- KALA $14.00
- AVG Volume (30 Days)
- WYY 58.6K
- KALA 198.2K
- Earning Date
- WYY 08-14-2025
- KALA 08-05-2025
- Dividend Yield
- WYY N/A
- KALA N/A
- EPS Growth
- WYY N/A
- KALA N/A
- EPS
- WYY N/A
- KALA N/A
- Revenue
- WYY $142,582,209.00
- KALA N/A
- Revenue This Year
- WYY $9.05
- KALA N/A
- Revenue Next Year
- WYY $12.24
- KALA N/A
- P/E Ratio
- WYY N/A
- KALA N/A
- Revenue Growth
- WYY 24.03
- KALA N/A
- 52 Week Low
- WYY $2.19
- KALA $2.92
- 52 Week High
- WYY $6.25
- KALA $11.20
- Technical
- Relative Strength Index (RSI)
- WYY 41.39
- KALA 59.52
- Support Level
- WYY $2.99
- KALA $5.35
- Resistance Level
- WYY $3.23
- KALA $8.49
- Average True Range (ATR)
- WYY 0.19
- KALA 0.81
- MACD
- WYY -0.01
- KALA 0.17
- Stochastic Oscillator
- WYY 27.59
- KALA 57.01
About WYY WidePoint Corporation
WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and an Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically, the company generates a majority of its revenue from the United States and the rest from Europe.
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.